XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.23.3

ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Acquisitions, Divestitures and Other Arrangements [Abstract] |
Divestitures | The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).
| Three Months Ended September 30,
| Net Proceeds |  | Divestiture (Gains)/Losses |  | Royalty Income
Dollars in millions | 2023 |  | 2022 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Diabetes business - royalties | $ | 220 |  |  | $ | 205 |  |  | $ | — |  |  | $ | — |  |  | $ | (217) |  |  | $ | (205) |
Mature products and other | 3 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | — |
Total | $ | 223 |  |  | $ | 206 |  |  | — |  |  | $ | — |  |  | $ | (217) |  |  | (205) |
| Nine Months Ended September 30,
| Net Proceeds |  | Divestiture (Gains)/Losses |  | Royalty Income
Dollars in Millions | 2023 |  | 2022 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Diabetes business - royalties | $ | 621 |  |  | $ | 562 |  |  | $ | — |  |  | $ | — |  |  | $ | (623) |  |  | $ | (595) |
Mature products and other (a) | 10 |  |  | 229 |  |  | — |  |  | (211) |  |  | — |  |  | (2) |
Total | $ | 631 |  |  | $ | 791 |  |  | $ | — |  |  | $ | (211) |  |  | $ | (623) |  |  | $ | (597) |
(a) Includes cash proceeds of $221 million and a divestiture gain of $211 million related to the sale of several mature products to Cheplapharm in the first quarter of 2022.
Licensing and Other Arrangements | The following table summarizes the financial impact of Keytruda* royalties, Tecentriq* royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Dollars in millions | 2023 |  | 2022 |  | 2023 |  | 2022
Keytruda* royalties | $ | (315) |  |  | $ | (268) |  |  | $ | (878) |  |  | $ | (732) |
Tecentriq* royalties | (24) |  |  | (24) |  |  | (78) |  |  | (68) |
Contingent milestone income | — |  |  | — |  |  | (36) |  |  | (46) |
Amortization of deferred income | (12) |  |  | (18) |  |  | (39) |  |  | (41) |
Biohaven sublicense income | — |  |  | (55) |  |  | — |  |  | (55) |
Other royalties and licensing income | (14) |  |  | (9) |  |  | (37) |  |  | (25) |
Total | $ | (365) |  |  | $ | (374) |  |  | $ | (1,068) |  |  | $ | (967) |

X
- Definition Acquisitions, Divestitures and Other Arrangements [Abstract] + References No definition available. + Details
Name: | bmy_AcquisitionsDivestituresandOtherArrangementsAbstract
Namespace Prefix: | bmy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Licensing and Other Arrangements + References No definition available. + Details
Name: | bmy_LicensingAndOtherArrangementsTableTextBlock
Namespace Prefix: | bmy_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 3 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3A Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4A Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-4B Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5A -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5A Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5B -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5D -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5D Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3A Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 20 -Topic 205 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-3 + Details
Name: | us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration